Call Us 080-41656200 (Mon-Sat: 10AM-8PM)
Free Shipping above Rs. 1499
Cash On Delivery*

Noninvasive Oral Alternative to Diabetic Insulin Drug Therapies


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days


Check Your Delivery Options

Rs. 2,675

Availability: In stock

  • Product Description

Noninvasive treatment alternatives for diseases from diabetes to hypercholerestemia are at the cutting edge of research. Although many noninvasive drug delivery routes, including oral, buccal, and dermal have been investigated no route has been fully approved for patient use by the Food and Drug Administration (FDA) standards as an alternative to current needle dependent insulin delivery. 10 12 This book focuses on two novel oral protein drug delivery systems α-Zr(IV) phosphate (α-ZrP)-protein-Divalent Metal Ion and α- Zr(IV) phosphate (α-ZrP)-protein- cationized Bovine Serum Albumin BSA. Glucose oxidase (GO) serves as a model protein in this book for noninvasive alternatives to lowering blood sugar in type I and II diabetics. However, instead of encapsulating GO, an oral drug treatment for diabetes, alternative proteins can also be encapsulated as oral drug treatments for ailments such as hypercholesterolemia. This experiment tests what ionized version of BSA (native BSA-TEPA (-25), BSA-TEPA (0), BSA-TEPA (-13), BSA-TEPA (+5), or divalent metal ion (Mg (II), Ca (II), or Ba (II)) intercalated into ZrP results in maximal GO binding and release in the intestinal region.

Product Specifications
SKU :COC53119
AuthorMomina Afrede
Number of Pages60
Publishing Year2014-02-19T00:00:00.000
Edition1 st
Book TypeBiophysics
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-06-08 00:00:00